Comparison of clinical outcomes of drug-coated balloons angioplasty vs. plain old balloons angioplasty for peripheral arterial disease: an umbrella meta-analysis

BackgroundPeripheral artery disease (PAD) affects millions globally, causing significant morbidity. Traditional treatments like plain old balloon angioplasty (POBA) have limited success due to high restenosis rates. Drug-coated balloon angioplasty (DCBA) has emerged as a promising alternative, local...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiacheng Li, Wei Lu, Lihong Lin, Jiawen Wu, Guobing Cheng, Qiang Hu, Yi Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1511268/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846161457140465664
author Jiacheng Li
Wei Lu
Lihong Lin
Jiawen Wu
Guobing Cheng
Qiang Hu
Yi Guo
author_facet Jiacheng Li
Wei Lu
Lihong Lin
Jiawen Wu
Guobing Cheng
Qiang Hu
Yi Guo
author_sort Jiacheng Li
collection DOAJ
description BackgroundPeripheral artery disease (PAD) affects millions globally, causing significant morbidity. Traditional treatments like plain old balloon angioplasty (POBA) have limited success due to high restenosis rates. Drug-coated balloon angioplasty (DCBA) has emerged as a promising alternative, locally delivering antiproliferative drugs like paclitaxel to reduce restenosis. However, the clinical outcomes of DCBA compared to POBA remain inconsistent across various studies.ObjectiveThis umbrella meta-analysis aimed to compare the clinical outcomes of DCBA and POBA in PAD patients, synthesizing data from multiple meta-analyses to provide a more robust evidence base.MethodsWe conducted an umbrella meta-analysis following PRISMA guidelines, systematically reviewing Cochrane Library, Embase, PubMed, and Web of Science. Studies were included if they compared DCBA and POBA in PAD patients, focusing on primary outcomes such as target lesion revascularization (TLR), primary patency (PP), all-cause mortality (ACM), and amputation. Secondary outcomes included restenosis, late lumen loss (LLL), and major adverse events (MAE).ResultsSixteen meta-analyses were included. DCBA significantly reduced the risk of TLR (OR: 0.41, 95% CI: 0.34–0.49), PP was significantly higher in DCBA (OR: 2.05, 95% CI: 1.53–2.75), and restenosis was lower (OR: 0.46, 95% CI: 0.41–0.51). No significant differences were found in ACM or amputation risk between the two groups. Heterogeneity was moderate to high across most outcomes.ConclusionDCBA provides significant advantages over POBA in reducing TLR and restenosis while maintaining vessel patency. However, the effects on ACM and amputation remain inconclusive. Future research should focus on long-term safety and identifying which patient subgroups benefit most from DCBA.Systematic Review Registrationhttps://www.crd.york.ac.uk/, PROSPERO [CRD42024591967].
format Article
id doaj-art-3f7cfa44809d4063a9dd9dbd3875fd5a
institution Kabale University
issn 2297-055X
language English
publishDate 2024-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj-art-3f7cfa44809d4063a9dd9dbd3875fd5a2024-11-21T06:23:47ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2024-11-011110.3389/fcvm.2024.15112681511268Comparison of clinical outcomes of drug-coated balloons angioplasty vs. plain old balloons angioplasty for peripheral arterial disease: an umbrella meta-analysisJiacheng Li0Wei Lu1Lihong Lin2Jiawen Wu3Guobing Cheng4Qiang Hu5Yi Guo6Department of Vascular Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, ChinaDepartment of Vascular Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, ChinaDepartment of Nosocomial Infection Control, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, ChinaDepartment of Vascular Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, ChinaDepartment of Vascular Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, ChinaDepartment of Vascular Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, ChinaDepartment of Nosocomial Infection Control, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, ChinaBackgroundPeripheral artery disease (PAD) affects millions globally, causing significant morbidity. Traditional treatments like plain old balloon angioplasty (POBA) have limited success due to high restenosis rates. Drug-coated balloon angioplasty (DCBA) has emerged as a promising alternative, locally delivering antiproliferative drugs like paclitaxel to reduce restenosis. However, the clinical outcomes of DCBA compared to POBA remain inconsistent across various studies.ObjectiveThis umbrella meta-analysis aimed to compare the clinical outcomes of DCBA and POBA in PAD patients, synthesizing data from multiple meta-analyses to provide a more robust evidence base.MethodsWe conducted an umbrella meta-analysis following PRISMA guidelines, systematically reviewing Cochrane Library, Embase, PubMed, and Web of Science. Studies were included if they compared DCBA and POBA in PAD patients, focusing on primary outcomes such as target lesion revascularization (TLR), primary patency (PP), all-cause mortality (ACM), and amputation. Secondary outcomes included restenosis, late lumen loss (LLL), and major adverse events (MAE).ResultsSixteen meta-analyses were included. DCBA significantly reduced the risk of TLR (OR: 0.41, 95% CI: 0.34–0.49), PP was significantly higher in DCBA (OR: 2.05, 95% CI: 1.53–2.75), and restenosis was lower (OR: 0.46, 95% CI: 0.41–0.51). No significant differences were found in ACM or amputation risk between the two groups. Heterogeneity was moderate to high across most outcomes.ConclusionDCBA provides significant advantages over POBA in reducing TLR and restenosis while maintaining vessel patency. However, the effects on ACM and amputation remain inconclusive. Future research should focus on long-term safety and identifying which patient subgroups benefit most from DCBA.Systematic Review Registrationhttps://www.crd.york.ac.uk/, PROSPERO [CRD42024591967].https://www.frontiersin.org/articles/10.3389/fcvm.2024.1511268/fullballoon angioplastypaclitaxelperipheral arterial diseasesystematic reviewumbrella review
spellingShingle Jiacheng Li
Wei Lu
Lihong Lin
Jiawen Wu
Guobing Cheng
Qiang Hu
Yi Guo
Comparison of clinical outcomes of drug-coated balloons angioplasty vs. plain old balloons angioplasty for peripheral arterial disease: an umbrella meta-analysis
Frontiers in Cardiovascular Medicine
balloon angioplasty
paclitaxel
peripheral arterial disease
systematic review
umbrella review
title Comparison of clinical outcomes of drug-coated balloons angioplasty vs. plain old balloons angioplasty for peripheral arterial disease: an umbrella meta-analysis
title_full Comparison of clinical outcomes of drug-coated balloons angioplasty vs. plain old balloons angioplasty for peripheral arterial disease: an umbrella meta-analysis
title_fullStr Comparison of clinical outcomes of drug-coated balloons angioplasty vs. plain old balloons angioplasty for peripheral arterial disease: an umbrella meta-analysis
title_full_unstemmed Comparison of clinical outcomes of drug-coated balloons angioplasty vs. plain old balloons angioplasty for peripheral arterial disease: an umbrella meta-analysis
title_short Comparison of clinical outcomes of drug-coated balloons angioplasty vs. plain old balloons angioplasty for peripheral arterial disease: an umbrella meta-analysis
title_sort comparison of clinical outcomes of drug coated balloons angioplasty vs plain old balloons angioplasty for peripheral arterial disease an umbrella meta analysis
topic balloon angioplasty
paclitaxel
peripheral arterial disease
systematic review
umbrella review
url https://www.frontiersin.org/articles/10.3389/fcvm.2024.1511268/full
work_keys_str_mv AT jiachengli comparisonofclinicaloutcomesofdrugcoatedballoonsangioplastyvsplainoldballoonsangioplastyforperipheralarterialdiseaseanumbrellametaanalysis
AT weilu comparisonofclinicaloutcomesofdrugcoatedballoonsangioplastyvsplainoldballoonsangioplastyforperipheralarterialdiseaseanumbrellametaanalysis
AT lihonglin comparisonofclinicaloutcomesofdrugcoatedballoonsangioplastyvsplainoldballoonsangioplastyforperipheralarterialdiseaseanumbrellametaanalysis
AT jiawenwu comparisonofclinicaloutcomesofdrugcoatedballoonsangioplastyvsplainoldballoonsangioplastyforperipheralarterialdiseaseanumbrellametaanalysis
AT guobingcheng comparisonofclinicaloutcomesofdrugcoatedballoonsangioplastyvsplainoldballoonsangioplastyforperipheralarterialdiseaseanumbrellametaanalysis
AT qianghu comparisonofclinicaloutcomesofdrugcoatedballoonsangioplastyvsplainoldballoonsangioplastyforperipheralarterialdiseaseanumbrellametaanalysis
AT yiguo comparisonofclinicaloutcomesofdrugcoatedballoonsangioplastyvsplainoldballoonsangioplastyforperipheralarterialdiseaseanumbrellametaanalysis